597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797634008610242560 |
|---|---|
| author | Patrick Forde Neru Munshi Ugur Sahin Oezlem Tuereci Akin Atmaca Petra Rietschel Dániel Deme Bala Öven Erdem Göker Istvan Lang Patrick Brück Michael Wenger Thomas Schell Kezi Ünsal-Kaçmaz Janet Markman Huyuan Yang |
| author_facet | Patrick Forde Neru Munshi Ugur Sahin Oezlem Tuereci Akin Atmaca Petra Rietschel Dániel Deme Bala Öven Erdem Göker Istvan Lang Patrick Brück Michael Wenger Thomas Schell Kezi Ünsal-Kaçmaz Janet Markman Huyuan Yang |
| author_sort | Patrick Forde |
| collection | DOAJ |
| first_indexed | 2024-03-11T12:01:46Z |
| format | Article |
| id | doaj.art-8417f9713f3d4d198f686b47521e32ce |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T12:01:46Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-8417f9713f3d4d198f686b47521e32ce2023-11-08T02:30:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0597597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancerPatrick Forde0Neru Munshi1Ugur Sahin2Oezlem Tuereci3Akin Atmaca4Petra Rietschel5Dániel Deme6Bala Öven7Erdem Göker8Istvan Lang9Patrick Brück10Michael Wenger11Thomas Schell12Kezi Ünsal-Kaçmaz13Janet Markman14Huyuan Yang15Aff3 grid.21107.350000000121719311Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore MD USAEMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA; a business of Merck KGaA, Darmstadt, Germany6BioNTech SE, Mainz, Rheinland-Pfalz, Germany9BioNTech SE, Mainz, Germany1 Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany10Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA1Clinexpert Ltd. Phase I Center Gyöngyös (Bugát Pál Hospital), Gyöngyös, Hungary2Yeditepe University Faculty of Medicine, Istanbul, Turkey3Ege University, Izmir, Turkey4PRA Health Sciences, Budapest, Hungary6BioNTech SE, Mainz, Rheinland-Pfalz, Germany6BioNTech SE, Mainz, Rheinland-Pfalz, Germany8BioNTech SE, Planegg, Germany9BioNTech US, Cambridge, MA, USA9BioNTech US, Cambridge, MA, USA11BioNTech US, Cambridge, MA, USA |
| spellingShingle | Patrick Forde Neru Munshi Ugur Sahin Oezlem Tuereci Akin Atmaca Petra Rietschel Dániel Deme Bala Öven Erdem Göker Istvan Lang Patrick Brück Michael Wenger Thomas Schell Kezi Ünsal-Kaçmaz Janet Markman Huyuan Yang 597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer Journal for ImmunoTherapy of Cancer |
| title | 597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer |
| title_full | 597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer |
| title_fullStr | 597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer |
| title_full_unstemmed | 597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer |
| title_short | 597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer |
| title_sort | 597 preliminary results from luca merit 1 a first in human phase i trial evaluating the fixed antigen rna vaccine bnt116 in patients with advanced non small cell lung cancer |
| work_keys_str_mv | AT patrickforde 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT nerumunshi 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT ugursahin 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT oezlemtuereci 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT akinatmaca 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT petrarietschel 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT danieldeme 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT balaoven 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT erdemgoker 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT istvanlang 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT patrickbruck 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT michaelwenger 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT thomasschell 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT keziunsalkacmaz 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT janetmarkman 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer AT huyuanyang 597preliminaryresultsfromlucamerit1afirstinhumanphaseitrialevaluatingthefixedantigenrnavaccinebnt116inpatientswithadvancednonsmallcelllungcancer |